OTHER GREAT NEWS OUT!!!
Neuro-Biotech's Solution for a Doctor near You: Early Detection for Alzheimer's and Chronic Fatigue Syndrome!
Neuro-Biotech Corp. Common Stock (USOTC:MRES)
Intraday Stock Chart
Today : Monday 20 September 2010
Click Here for more Neuro-Biotech Corp. Common Stock Charts.
Neuro-Biotech Corporation (PINKSHEETS: MRES) (OTCQB: MRES) is a worldwide based biotechnological enterprise involved in the unique international niche of clinical neuroscience diagnostic testing. Neuro-Biotech's presently has the opportunity to market 12 clinical "Neuro Blood Tests" through partnerships. Neuro-Biotech's proprietary diagnostic tests are without equal in being rapidly done as an essential complement to current clinical laboratory testing procedures, by being non-invasive, sensitive, and reliable. This will provide general practitioners and specialists alike, useful medical parameters in the analysis and treatment of workplace stress-related diseases and mental-health disorders, such as Alzheimer's.
As a result of more than 20 years of research and development (R&D), Neuro-Biotech Corp.'s specific expertise is the understanding of the communication between the brain and the human body and their various influences on the peripheral systems, in order to maintain the internal equilibrium of a person's state of mind.
This exclusive understanding of the relationships between the neurotransmitter families within the brain led to the development of a portfolio of in vitro diagnostic blood tests. They will be used for the detection, prevention, monitoring and follow-up of the major psycho-social environmental diseases. They can be stress-related, socio-professional and occupational diseases, such as Chronic Fatigue Syndrome (CFS), Great Anxiety (GA), Panic Syndrome (PS); Cardiovascular diseases like Essential Hypertension or Arrhythmia; Neurodegenerative diseases such as Alzheimer or Parkinson's Disease as well as Mental-Health Disorders in the vein of Depression and Schizophrenia
Caregivers can now evaluate and establish an individual's ability to react to stress by monitoring bio-indicators within the blood or other biological fluids. Efficient and improved patient supervision, treatment and follow-up care can be instituted.
Clinical Neuroscience-related diseases can be difficult
to diagnose and complex to treat.
If we don't know the full state of health of an individual
and the progression of the therapy...
How can we truly manage the care and rehabilitation?
Neuro-Biotech Corp. has the solution!
SOURCE Neuro-Biotech Corp.
